References

1. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullaryplasmacytomas with solitary and multiple plasma cell tumors of bone. J ClinOncol. 1983; 1:255-26. PubMed | Google Scholar


2. Galieni P, Cavo M, Avvisati G, et al. Solitary plasmacytoma of bone and extramedullaryplasmacytoma: two different entities? Ann Oncol. 1995; 6:687-691. PubMed | Google Scholar


3. Kochbati L, Kédidi Ben Romdhane N, Mrad K, Nasr C, et al. Plasmocytome solitaire osseux : aspects th érapeutiques et évolutifs. Cancer /Radiothérapie. 2004; 8(2): 70-74. PubMed | Google Scholar


4. Bataille R, Sany J. Solitary myeloma: Clinical and prognostic features of a review of 114 cases. Cancer. 1981; 48:845-51. PubMed | Google Scholar


5. Maalej M, Moalla M. Plasmocytomes solitaires osseux : problèmes nosologiques et thérapeutiques. Tunis Med. 1989;67:661-4. PubMed | Google Scholar


6. Mendenhall CM, Thar TL, Million RR. Solitary plasmacytoma of bone and soft tissue. Int J RadiatOncolBiolPhys. 1980; 6:1497-1501. PubMed | Google Scholar


7. Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmocytoma of bone: Mayo Clinic experience. Int J RadiatOncolBiolPhys. 1989; 16:43-8. PubMed | Google Scholar


8. Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J RadiatOncolBiolPhys. 1998; 41:1063-1067. PubMed | Google Scholar


9. Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology. 2000; 14:101-111. PubMed | Google Scholar


10. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J RadiatOncolBiolPhys. 2001; 50:113-120. PubMed | Google Scholar


11. Aviles A, Huerta-Guzman J, Delgado S, et al. Improved outcome in solitary bone plasmacytoma with combined therapy. HematolOncol .1996; 14:111-117. PubMed | Google Scholar


12. Jackson A, Scraffe JH. Prognostic signifcance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone. Eur J Cancer. 1990;26:363-371. PubMed | Google Scholar


13. Kyele RA. Monoclonal gammapathy of undetermined signifcance and solitary plasmocytoma. HaematolOncolClin North Am. 1997;11: 71-87. PubMed | Google Scholar


14. Shih LY, Dunn P, Leung WM, et al. Localisedplasmocytomas in Taiwan: comparison between extramedullaryplasmocytoma and solitary plasmocytoma of bone. Br J Cancer. 1995;71: 128-33. PubMed | Google Scholar


15. Ellis PA, Colls BM. Solitary plasmocytoma of bone: clinical feature, treatment and survival. HaematolOncol. 1992; 10:207-11. PubMed | Google Scholar


16. Liebross RH, Ha CS, Cox JD, et al. Clinical course of solitary extramedullaryplasmacytoma. RadiotherOncol. 1999;52(3): 245-249. PubMed | Google Scholar


17. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullaryplasmacytoma: Tumor occurrence and therapeutic concepts. Cancer. 1999; 85: 2305-2314. PubMed | Google Scholar


18. Miller FR, Lavertu P, Wanamaker JR, et al. Plasmacytomas of the head and neck. Otolaryngol Head Neck Surg. 1998;119(6): 614-6. PubMed | Google Scholar


19. Michalaki VJ, Hall J, Henk JM, et al. Defnitive radiotherapy for extramedullaryplasmacytomas of the head and neck. Br J Radiol. 2003; 76:738-741. PubMed | Google Scholar


20. Bachar G, Goldstein D, Brown D, et al. Solitary extramedullaryplasmacytoma of the head and neck long-term outcome analysis of 68 cases. Head Neck. 2008; 30(8): 1012-1019. PubMed | Google Scholar


21. Bush SE, Goffnet DR, Bagshaw MA. Extramedullaryplasmacytoma of the head and neck. Radiology. 1981 Sep;140(3):801-5. PubMed | Google Scholar